Patents by Inventor Kilian Conde-Frieboes

Kilian Conde-Frieboes has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Novel Peptides for Use in the Treatment of Obesity
    Publication number: 20080039387
    Abstract: The present invention relates to novel peptide compounds which are effective in modulating one or more melanocortin receptor types, to the use of the compounds in therapy, to methods of treatment comprising administration of the compounds to patients in need thereof, and to the use of the compounds in the manufacture of medicaments. The compounds of the invention are of particular interest in relation to the treatment of obesity as well as a variety of diseases or conditions associated with obesity.
    Type: Application
    Filed: November 4, 2005
    Publication date: February 14, 2008
    Applicant: Novo Nordisk A/S
    Inventors: Ulrich Sensfuss, Kilian Conde Frieboes
  • Peptides for use in treating obesity
    Publication number: 20070244054
    Abstract: Novel cyclic and linear peptides of the formula R1—X—X1—X2—X3—X4—X5—X6—X7—X8—X9—X10—X11—R2 are useful in the treatment of obesity are provided.
    Type: Application
    Filed: November 7, 2005
    Publication date: October 18, 2007
    Applicant: Novo Nordisk A/S
    Inventors: Ulrich Sensfuss, Kilian Conde Frieboes, Leif Christensen, Ingrid Petterson, Thomas Hansen, Michael Ankersen, Kjeld Madsen
  • Compounds and compositions for treating obesity
    Publication number: 20070185128
    Abstract: Described herein are novel and useful compounds of the general formula Compounds of this invention can advantageously exhibit melanocortin receptor agonist activity. New and useful compounds comprising such a chemical structure and methods of modulating melanocortin receptor activity in a subject (and promoting, inducing, and/or enhancing the treatment or prevention of related diseases) by administering such a compound or composition also are described.
    Type: Application
    Filed: November 21, 2003
    Publication date: August 9, 2007
    Inventors: Kilian Conde-Frieboes, Michael Ankersen, Ulrich Sensfuss, Birgitte Wulff, Henning Thogersen, Philipp Lustenberger, Klaus Rudolf, Bernd Krist, Stephan Muller, Dirk Stenkamp, Marcus Schindler, Heike Wieland, Kirsten Arndt
  • Novel Melanocortin Receptor Agonists
    Publication number: 20070027091
    Abstract: Small cyclic peptides of the formula X1-X2-X3-X4-X5-X6-X7-R1 comprising 7-12 amino acid residues are provided. Said peptides are MC4 receptor agonists, and thus useful in the treatment of obesity and related diseases.
    Type: Application
    Filed: March 30, 2006
    Publication date: February 1, 2007
    Applicant: Novo Nordisk A/S
    Inventors: Kilian Conde-Frieboes, Ulrich Sensfuss, Kjeld Madsen, Nils Johansen, Leif Christensen, Thomas Hansen, Birgitte Wulff